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ABSTRACT
Recombinase mediated cassette exchange (RMCE)
is a process in which site-specific recombinases
exchange one gene cassette flanked by a pair of in-
compatible target sites for another cassette flanked
by an identical pair of sites. Typically one cassette is
present in the host genome, whereas the other gene
cassette is introduced into the host cell by chemical
or biological means. We show here that the fre-
quency of cassette exchange is dependent on the
relative and absolute quantities of the transgene
cassette and the recombinase. We were able to suc-
cessfully modify genomic targetsnot only byelectro-
poration or chemically mediated gene transfer but
also by using an adenovirus vector carrying both
thetransgene cassette tobeinserted andtherecom-
binase coding region. RMCE proceeds efficiently in
cells in which the adenovirus vector is able to repli-
cate. In contrast, insufficient quantities of the trans-
genecassetteareproducedincellsinwhichthevirus
cannotreplicate.Additionaltransfectionofthetrans-
gene cassette significantly enhances the RMCE fre-
quency. This demonstrates that an RMCE system in
the context of a viral vector allows the site directed
insertion of a transgene into a defined genomic site.
INTRODUCTION
Foreign DNA can be transported into eukaryotic cells by
physical, chemical or biological methods (e.g. microinjec-
tion, liposomes, electroporation, gene-gun or viral vectors)
(1). Stable integration of the foreign DNA will only occur
in a small proportion of the cells that have taken up the
DNA. Integration of the foreign DNA is mediated by
cellular DNA repair enzymes and occurs at random sites
of the host genome. If the foreign DNA contains se-
quences that are identical to the host genome, it can be
inserted by homologous recombination in a small fraction
of the transduced cells. Retroviral vectors integrate their
DNA into the host genome eﬃciently and murine
leukemia virus (MLV) and lentivirus-based vectors are ex-
cellent tools for both animal transgenesis and gene therapy
(2,3). However, retroviral vectors suﬀer from some limita-
tions. In the context of animal transgenesis, the limited
packaging capacity of retroviral vectors dictates the use
of small transgene expression cassettes, which often lack
the regulatory elements required for the tissue-speciﬁc and
abundant expression of the transgene (4). The integration
at random sites often places the transgene into an envir-
onment that is not supportive of its expression.
MLV-based vectors are additionally silenced by epigenetic
mechanisms. In the context of gene therapy, retroviral
vectors also carry the risk of insertional mutagenesis
(2,5). If a transgene or a therapeutic gene would be
inserted into the host genome at a pre-selected site,
abundant and continuous expression of the foreign
DNA could be accomplished in the absence of genome
mutagenesis. In principle targeting of a deﬁned site in a
eukaryotic genome can be achieved by using either
DNA-base pairing or sequence-speciﬁc DNA–protein
interactions (6). Site-speciﬁc recombinases can insert
transgenes, introduced into the host cell by chemical,
physical or biological means, into deﬁned genomic
sites. If the transgene cassette is ﬂanked by a pair of in-
compatible recombinase target sites, it can be inserted into
a genomic target which carries the same arrangement of
two incompatible target sites without the introduction of
excess plasmid sequences. This process is termed recom-
binase mediated cassette exchange (7–9). The molar
*To whom correspondence should be addressed. Tel: +44 1224 716645; Fax: +44 1224 716629; Email: a.kolb@abdn.ac.uk
Present addresses:
David A. Sorrell, Cambridge Molecular Therapeutics Programme, Department of Oncology, Hutchison/MRC Research Centre, Hills Road,
Cambridge CB2 0XZ, UK
Jo-Ann Smith, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G1 1XW, UK
Published online 5 April 2010 Nucleic Acids Research, 2010, Vol. 38, No. 11 e123
doi:10.1093/nar/gkq192
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.excess of the newly introduced cassette leads to an eﬀect-
ive exchange of the cassette in the genome (pre-
sent in one copy) with the transfected transgene cassette
(present as multiple copies per cell). The recombinase
target sites themselves can be inserted into the host
cell genome at random or by homologous
recombination (3).
We show here that the site-speciﬁc recombinase Cre is
able to mediate integration of a transgene into a prede-
ﬁned genomic site not only in the form of naked DNA but
also in the context of a viral vector. However, the integra-
tion eﬃciency is highly dependent on the relative and
absolute amounts of transgene DNA and recombinase
protein present in the cell. In addition, in order to
achieve suitable concentrations of the transgene cassette,
the viral vector needs to be replication competent. The
experiments shown in here demonstrate that the
elements of a recombinase mediated cassette exchange
approach can be delivered in the context of a viral
vector (i.e. adenovirus) which is regularly used for gene
therapy. Whereas adenovirus DNA remains episomal
throughout the viral life cycle a transgene embedded in
the viral DNA can be mobilized by Cre such that it inte-
grates site-speciﬁcally into the host genome. This strategy
will pave the way for a safer approach to gene therapy and
also for the targeted delivery of transgenes to speciﬁc
genomic loci in transgenic animals.
MATERIALS AND METHODS
Cells
Human embryonic kidney cells (HEK 293; ECACC No:
85120602) were cultivated in high glucose Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with
10% foetal calf serum, Penicillin/Streptomycin and
2mM Glutamine. Baby hamster kidney cells (BHK 21;
ECACC No: 85011433) were cultivated in minimum
essential medium (MEM) supplemented with 10% foetal
calf serum, Penicillin/Streptomycin, 2mM Glutamine,
0.1mM non-essential amino acids and 1.0mM sodium
pyruvate. HM1 mouse embryonic stem cells (10) and
HC11 mouse mammary gland cells (11) were cultivated
as described (12). The cell line HM1 RMCE2272-98 has
been described before and contains an HPRT selection
marker gene inserted into the murine b-casein gene by
homologous recombination (13). Cell culture reagents
were purchased from Invitrogen, foetal calf serum was
purchased from Sigma.
HEK293 and HC11 cells were transfected using
the Gene Juice Reagent (Novagen) according to the manu-
facturer’s recommendations. HM1 embryonic stem (ES)
cells were electroporated using a Bio-Rad Gene Pulser
using various conditions as indicated in Table 2. HC11
cells were electroporated in a 4mm cuvette at 250V and
950mF. Protein transfections were carried out using the
ProteoJuice reagent (Novagen) as suggested by the
supplier.
All transfections were carried out using identical
amounts of plasmid DNA. In control reactions the
plasmids pCMV-bgal (Clontech) or pBluescript
(Stratagene) were co-transfected.
DNA constructs
The plasmid pBK2272-HPRT was derived from the
plasmid pPGK-HPRT (14) from which the 2.9-kb
EcoRI insert was excised and inserted into the plasmid
pBK-CMV-2272, which carries a pair of incompatible
lox sites (loxP and lox2272) at the fringes of its multiple
cloning site. pB2272-neo is based on the plasmid pB2272
(13) and carries the same pair of incompatible lox sites at
the fringes of its multiple cloning site. The PGK-neo
expression cassette is inserted as an EcoRI/HindIII
1.8-kb fragment. The plasmid pB-lox1/2-hyg/luc2 was
described previously (15).
The plasmids used for the generation of adenovirus
vectors are based on the Stratagene AdEasy system and
the system was used as recommended by the supplier. The
plasmid pShuttle was used as basis for the generation of
vectors carrying (i) a Cre-expression cassette derived from
the plasmid pMC1-Cre (16), (ii) a PGK-neo expression
cassette derived from pB2272-neo and (iii) in case of the
plasmid pShuttle-G5 two copies of the chicken b-globin
insulator element (derived as a 2.5-kb EcoRI/BamHI
fragment from the plasmid pJC13-1, a gift of Gary
Felsenfeld; NIH, Bethesda). Average virus titres were in
the range of 10
6pfu/ml. Infections were performed at an
multiplicity of infection (MOI) of one unless stated
otherwise.
The vector pB-bcas7-2272-hytk carries a PGK-hytk
(hygromycin-phosphotransferase thymidine kinase fusion
gene) expression cassette ﬂanked by a pair of incompatible
lox sites (lox2272 and loxP) embedded into the backbone
of a mouse b-casein gene. The construct was derived from
the plasmids pB-bcas6 and pB2272-hytk (13) by in vitro
Cre mediated recombination. In order to generate stable
cell clones an 8-kb NheI/SﬁI fragment was excised from
the vector and electroporated into HEK 293 cells (1mgo f
DNA in 1 10
7 cells in a 0.2cm cuvette at 110V). Cells
were selected in medium containing 100mg/ml of
Hygromycin B.
The plasmid pDSred-mito-2272neo was derived from
the Clontech plasmid pDSred2-mito, which was cut with
NheI and blunt ended using Escherichia coli DNA poly-
merase I. The PGK-neo cassette ﬂanked by a tandem pair
of lox2272 sites was isolated from pB2272-neo-2272 as a
1.9-kb SacI/KpnI fragment. The insert was also blunt-
ended using E. coli DNA polymerase I.
PCR
polymerase chain reaction (PCR) ampliﬁcations were
done using Taq polymerase from various suppliers.
Oligonucleotides were purchased from MWG or
Sigma-Genosys. Primer sequences, amplicon size and an-
nealing temperatures are given in Table 1. Template DNA
for PCR analyses was isolated as described (12). Real-time
PCR ampliﬁcations were carried out using the Roche
Light-Cycler with Roche reagents as described (17).
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Adenovirus was prepared using the Stratage AdEasy
system as recommended by the supplier. The virus titre
was determined using a TCID50 protocol.
Immuno-histochemistry
Cells were seeded onto coverslips in a 24-well plate and
transfected with plasmid DNA and/or protein. 48h
post-transfection, medium was removed and the cells
were washed in PBS, ﬁxed in 2% para-formaldehyde for
20min and then washed again three times with PBS. Cells
were blocked in 3% BSA in 1xTBST overnight at 4 C. An
MBP-speciﬁc rabbit antiserum (New England Biolabs)
was added at a 1:200 dilution in 1xTBST and incubated
at room temperature for 2h. The cells were washed three
times for 10min in 1  TBST. Then the second antiserum
(goat-anti-rabbit FITC linked) was added at a dilution of
1:100 and the cells on the coverslips were incubated at
room temperature for 2h in the dark. Cells were then
washed as before. The cover-slips were mounted in a
mounting medium containing DAPI (40,6-diamidino-2-
phenylindole; Vector Labs) and photographed at a mag-
niﬁcation of 100-fold on a Leica ﬂuorescent microscope.
RESULTS
The Cre recombinase system can be used to insert genes at
predeﬁned sites in the mammalian genome which have
been tagged with a lox target site. This has been
demonstrated in a number of cell types and also (albeit
at reduced eﬃciency) in fertilized mouse oocytes (7–9). We
have utilized the Cre recombinase to insert genes into the
murine b-casein gene with a view to expressing these genes
in the milk of transgenic animals (4,18–20). Using recom-
binase mediated cassette exchange for this approach
allows the target speciﬁc insertion of a transgene in a
deﬁned orientation without introducing any excess
vector sequences. In order to express proteins eﬀectively
in the milk of transgenic animals, we have chosen the
b-casein gene as a target site which is able to equip an
inserted transgene with all required regulatory elements
to allow for abundant expression of the transgene in the
lactating mammary gland (3,18).
Electroporation conditions determine the frequency of
site-speciﬁc recombination
Electroporation is the method of choice for the transfer
of DNA into embryonic stem cells. However, diﬀerent
electroporation conditions have been published for the
successful DNA transfer into mouse ES cells (21,22).
We therefore tried to delineate the parameters which
would best support site-speciﬁc recombination in HM1
ES cells. We set out to analyse the precise electroporation
conditions which provide the optimum recombination fre-
quency. A pair of incompatible lox sites (loxP and
lox2272) in conjunction with a b-galactosidase open
reading frame and a hytk (hygromycin-
phosphotransferase thymidine kinase fusion gene) selec-
tion marker expression cassette was inserted into the
second exon of the b-casein gene in HM1 embryonic
stem cells using sequential homologous and site-speciﬁc
recombination (13). The ATG of the b-casein gene was
deleted during that process, such that the ATG of
b-galactosidase is the ﬁrst translation start codon in a
chimeric mRNA initiating at the ﬁrst exon of the
b-casein gene (Figure 1). The resulting cell line HM1
RMCE2272-gal/hytk (GH1) was then transfected with
the plasmid pB2272-neo together with a two-fold excess
of a Cre expression vector. The cells were selected in
medium containing 200mg/ml G418. Under these
Table 1. Primer combinations used for PCR analysis
Name Sequence Annealing temperature ( C) Amplicon length (bp)
bcas10 50 GTA ACC ATA AAA CTT CTC CAG GGA CTT GG 30
bcas3 50 AGA GGA TCC GTA AGA CGT CAC CTG CTC ACC 30 55 1317
bcas10 50 GTA ACC ATA AAA CTT CTC CAG GGA CTT GG 30
bgalint.1 50 TGT TGG TCA AAG TAA ACG ACA TGG TGA CT 30 55 1203
neoint.4 50 GCG CAT CGC CTT CTA TCG CCT TCT TGA C 30
bcas3 50 AGA GGA TCC GTA AGA CGT CAC CTG CTC ACC 30 60 1023
PGK1 50 CGA GGC CCG GCA TTC TGC ACG C 30
CMVseq.1 50 GGA CTT TCC AAA ATG TCG TA 30 50 2941
PGK5 50 AAG CGC ATG CTC CAG ACT GCC TTG GGA AA 30
CMVseq.1 50 GGA CTT TCC AAA ATG TCG TA 30 51 421
PGK5 50 AAG CGC ATG CTC CAG ACT GCC TTG GGA AA 30
pBKpA 50 GCT ATT GCT TTA TTT GTA ACC ATT A 30 52 622
hytk1 50 AGA GCT GCA TCA GGT CGG AGA CGC TGT CG 30
bcas3 50 AGA GGA TCC GTA AGA CGT CAC CTG CTC ACC 30 57 1147
bcas6 50 TAA GGG CCA GAG TAG ATC 30
hytk2 50 TCC TGG ATT ACG ACC AAT CG 30 48 215
bcas6 50 TAA GGG CCA GAG TAG ATC 30
PGK5 50 AAG CGC ATG CTC CAG ACT GCC TTG GGA AA 30 50 936
neoint.4 50 GCG CAT CGC CTT CTA TCG CCT TCT TGA C 30
pBKpA 50 GCT ATT GCT TTA TTT GTA ACC ATT A 30 51 1074
neoint.2 50 CCA GTC ATA GCC GAA TAG CCT CTC CAC CC 30
pBKpA2 50 TTC ACT GCA TTC TAG TTG TGG TTT GTC 30 56 1106
DSred-1R 50 AGC GCA TGA ACT CGG TGA TGA C 30
CMVseq.1 50 GGA CTT TCC AAA ATG TCG TA 30 59 529
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marker gene at random sites or by site-speciﬁc recombin-
ation will survive. We found that, surprisingly, the fre-
quency of site-speciﬁc integration was heavily dependent
on the electroporation conditions used (Table 2). At 250V
and 960mF almost all of the colonies selected carried a
site-speciﬁc insertion of the neo gene at the b-casein
locus. In contrast, transfections carried out at 800V and
3mF, although generating the same number of resistant
colonies, showed no site-speciﬁc insertion of the neo
gene into the predeﬁned b-casein target site (Table 2).
As we suspected that the amount of Cre protein ex-
pressed under these diﬀerent electroporation conditions
may be critical for the frequency of the RMCE reaction,
we analysed the impact of the Cre protein concentration
on the recombinase mediated cassette exchange (RMCE)
frequency (Figure 2). HEK 293 cells were transfected with
the plasmids pB2272-neo and pBK2272-HPRT. RMCE
between the two plasmids can readily be detected and
quantiﬁed by PCR (Figure 2A). Subsequently, varying
amounts of MBP-Cre protein (23) were transfected into
the cells using the Proteo-Juice reagent and the RMCE
A
B
Figure 1. (A) Schematic representation of the murine b-casein gene and its derivatives after homologous recombination and RMCE. Exons of the
b-casein gene are indicated as solid boxes, the neomycin (neo) and hytk selection marker genes are indicated as solid arrows, respectively and the
b-galactosidase gene (b-gal) is indicated as a hatched arrow. The PGK promoter elements directing expression of the selection marker genes are
indicated as black arrowheads. The positions of the lox2272 and loxP sites and the translational start codon (ATG) are marked by vertical arrows.
The primer binding sites (horizontal arrows) used for genotyping and the sizes of the expected PCR products are indicated. (B) PCR analysis of
genomic DNA isolated from the cell clones HM1 RMCE2272-gal/hytk (GH1), and the cell clone HM1 N1-2272 derived from it. A 1317-bp band is
detected in both samples and represents the unmodiﬁed b-casein allele. HM1 RMCE2272-gal/hytk (GH1) cells carry an insertion of a b-galactosidase
open reading frame and a PGK-hytk expression cassette at one of the b-casein alleles as indicated by the occurrence of a 1203-bp PCR product. Cell
clone HM1 N1-2272 was derived after an RMCE event which exchanged the b-gal and hytk genes for the neo selection marker gene. The correct
modiﬁcation is indicated by the generation of a 1023-bp PCR product and the concomitant loss of the 1203-bp band. Phage  DNA digested with
HindIII and EcoRI was used as molecular weight marker.
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demonstrate that the RMCE frequency is indeed directly
correlated with the concentration of Cre protein present in
the cell. If 10mg of MBP-Cre protein are tranfected per 10
5
cells, 14% of the transfected DNA undergo RMCE
(Figure 2B). MBP-Cre protein can be detected by
immuno-histochemistry in around 5–7% of the cells
(Figure 2C). As transfection of DNA and protein will
not have occurred necessarily in the same cells, it is
possible that the maximum frequency of RMCE may be
higher than 14%. Alternatively, as the RMCE reaction
will reach an equilibrium of the diﬀerent recombination
products (which can be formed via either or both of the
lox sites), the 14% RMCE product detected may represent
the equilibrium state of the RMCE reaction.
Chemical-mediated gene transfer supports RMCE
Most researchers have used electroporation to mediate
DNA transfection in the context of RMCE experiments
(8,24,25). We wanted to determine whether electroporation
per se is a signiﬁcant stimulus for the eﬃcient integration of
DNA via RMCE or whether (in our hands) a chemical
(rather than a physical) method for DNA transfer would
work as well as electroporation. We therefore used a
chemical DNA transfer methods (Gene Juice, Novagen)
to mediate site-speciﬁc insertion of the transgene cassette.
μ
A
BC
Figure 2. (A) Schematic representation of the plasmids pB2272-neo and pBK2272-HPRT. The neomycin resistance marker genes (neo) are indicated
as solid arrows. The PGK promoter is indicated as an arrowhead. The HPRT selection marker gene is indicated as a striped arrow. The primer
binding sites (horizontal arrows) used for genotyping and the sizes of the expected PCR products are indicated. (B) Quantitative PCR analysis of
recombinase mediated cassette exchange in HEK 293 cells. Cells were transfected with equimolar amounts of the plasmids pBK2272-HPRT and
pB2272-neo. Twenty four hours post-plasmid transfection the cells were transfected with diﬀerent amounts of an MBP-Cre fusion protein using the
Proteo-Juice reagent (Novagen). DNA was isolated from cells 36h later and analysed by real-time PCR using the primer pair neoint.2/pBKpA2
(yielding a 1106-bp fragment) to quantify the concentration of the input plasmid pBK-2272HPRT and the primer pair neoint.4/pBKpA (yielding a
1073-bp fragment) to quantify the concentration of RMCE product generated. The concentrations are presented as pg RMCE product per ng input
plasmid in correlation with the amount of MBP-Cre protein transfected into 1 10
5 cells. (C) Immunohistochemistry of cells transfected with the
plasmids pB2272-neo and pBK2272-HPRT and the protein MBP-Cre (or the plasmid pMC1-Cre; right panel). The MBP section of the protein was
detected using a 1:200 dilution of an MBP-speciﬁc rabbit antiserum and a goat-anti-rabbit FITC-linked secondary antiserum.
Table 2. Recombinase mediated cassette exchange eﬃciency is
dependent on electroporation conditions
Electroporation
conditions
Number of
colonies
Site-speciﬁc
integration (%)
250V/960mF (+Cre) 221±17 100 (12 of 12)
250V/960mF (+Cre) 73±8 92 (11 of 12)
250V/960mF (+Cre) 154±7 83 (10 of 12)
250V/960mF (+Cre) 68±6 92 (11 of 12)
800V/3mF (+Cre) 53±5 0 (0 of 12)
800V/3mF (+Cre) 21±2 0 (0 of 12)
800V/3mF (+Cre) 46±3 0 (0 of 12)
800V/3mF (+Cre) 61±7 0 (0 of 12)
800V/3mF(  Cre) 57±3 nd
800V/3mF(  Cre) 62±6 nd
Colony numbers are average values from four cell culture dishes
(±SD). Site-speciﬁc integration was assessed by PCR as shown in
Figure 1. nd: not determined.
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frequencies with the Gene Juice reagent, this experiment
was carried out in a derivative of the mouse mammary
gland cell line HC11 cells termed HC11-bcas-F9 (18).
The cells carry the same modiﬁcation as the HM1 ES
cells used above and were transduced with the plasmids
pB2272-neo and pMC1-Cre using the Gene Juice reagent
and, in parallel, by electroporation. Seventeen percent of
the selected cell colonies carried the correct site-speciﬁc
integration of the marker gene into the b-casein gene
when the cells were transfected using Gene Juice.
Electroporation with the same construct lead to 28% of
the cells carrying the correct integration. The absolute
number of resistant cell colonies was similar for both tech-
niques (Table 3), however, addition of Cre to the trans-
fection mixture decreased the number of resulting
selection resistant colonies when the cells were trans-
fected with Gene Juice and increased the number of resist-
ant colonies when the cells were electroporated.
This suggests that the transfection method can indeed
have an inﬂuence on the relative frequency of random in-
tegration and recombinase mediated integration. Gene
Juice mediated transfections may present the DNA in a
way that is more amenable to random insertion than
DNA brought into the cell by electroporation. This in
turn may be dependent on the diﬀerent biochemical envir-
onments the DNA is exposed to in the two DNA transfer
methods. However, these results also demonstrate that
transfection methods other than electroporation can be
used successfully to bring about recombinase mediated
cassette exchange.
The recombinase expression cassette and the transgene
cassette can be delivered in one plasmid
We then wanted to analyse the eﬃciency with which the
recombinase and the transgene cassette mediate RMCE
reactions in the context of a biological gene transfer
vehicle i.e. a viral vector. Transfections aimed at achieving
recombinase mediated cassette exchange typically utilize
an excess of Cre expression plasmid over the plasmid
carrying the transgene construct (13,26–28). In the experi-
ments described above a 2- or 3-fold excess of Cre expres-
sion construct was used. In the context of a viral vector
carrying both the transgene and the recombinase gene, the
genes would be present at an equimolar ratio. In order to
test whether such a construct would support site-speciﬁc
recombination of a transgene, a plasmid carrying the
neomycin resistance marker cassette derived from
pB2272-neo (ﬂanked by a pair of incompatible lox sites)
was joined to a Cre expression cassette in the context of
the plasmid pShuttle (Stratagene) (Figure 3A). First, the
construct was co-transfected into BHK cells together with
an acceptor plasmid (pBK2272-HPRT) carrying the same
pair of lox sites. As shown in Figure 3B the plasmid
(termed pShuttle-H6) supported site-speciﬁc recombin-
ation with the acceptor plasmid in the presence or
absence of any additional Cre expression vector (see
lanes pShuttle-H6 and pShuttle-H6+pMC1-Cre) as
demonstrated by the occurrence of the indicative 421-bp
PCR product in a transient transfection.
The construct pShuttle-H6 was then transfected into
HM1-2272-98 cells (13). These derivatives of HM1 cells
carry a modiﬁed b-casein locus incorporating an HPRT
selection marker gene ﬂanked by the loxP/lox2272 pair of
Cre target sites. Interestingly, none of the G418 resistant
cell clones derived from this transfection carried a
site-speciﬁc insertion of the neo cassette at the b-casein
gene even if electroporations were carried out under the
conditions which had previously lead to a high eﬃciency
of RMCE (cf. Table 1). In the plasmid pShuttle-H6 the neo
expression cassette and the Cre expression cassette are
placed in tandem. A corresponding plasmid in which the
orientation of the neo expression cassette was reversed also
failed to yield any G418 resistant cell clones which carried a
site-speciﬁc insertion after transfection into HM1
RMCE2272-98 cells (data not shown). We have previously
shown that expression cassettes in close vicinity can inter-
fere with each others expression (15). Therefore the vector
was modiﬁed by the insertion of two copies of the chicken
b-globin insulator between the Cre and neo expression cas-
settes. The resulting vector (pShuttle-G5, Figure 5A) was
again transfected into HM1-2272 98 cells and G418 resist-
ant colonies were derived. This time the vast majority of
stable cell clones (85%) had taken up the neo cassette by
site-speciﬁc recombination (as shown for representative
clones in Figure 4). This conﬁrms that it is possible to
provide the Cre expression cassette and the transgene
which is to be integrated into the host genome in a single
contiguous DNA segment. The results also demonstrate
that vector design is a critical factor determining the eﬃ-
ciency of RMCE.
An adenovirus vector can mediate successful RMCE
We therefore established an adenovirus vector based on
the plasmid pShuttle-G5 and tested its ability to support
site-speciﬁc recombination in HEK 293 and BHK cells.
Table 3. Recombinase mediated cassette exchange eﬃciency after liposome transfection and electroporation in two experiments conducted in
parallel
Selection pMC1-Cre Colonies Gene Juice transfection
(1.5pg DNA per cell)
Colonies electroporation
(2pg DNA per cell)
G418 ( ) 178, 131 78, 40
G418 (+) 42, 38 (3 of 17 positive, 18%) 178, 155 (7 of 25 positive, 28%)
G418/Ganc. ( ) 133, 146 54, 78
G418/Ganc. (+) 71, 87 208, 218
pMC1-Cre was co-transfected with the plasmid pB2272-neo in a 3:1 ratio.
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around 1 10
6pfu/ml. This is signiﬁcantly lower than
the titer we obtained for the control virus encoding the
b-galactosidase gene, which yields a titer in excess of
1 10
8pfu/ml in our hands. We suspect that this is due
to the fact that the size of the total insert is  7kb, which is
close to the maximum packaging capacity of the AdEasy
vector system (7.5kb), which carries deletions in the E1
and E3 genes. When infected with the b-galactosidase
control adenovirus BHK and HEK 293 cells at an MOI
of 10, essentially all cells become infected, demonstrating
that both cell types are susceptible to adenovirus infection
(data not shown).
HEK 293 cells carry segments of the adenovirus genome
which are deleted from the recombinant virus and com-
plement the viral vector to allow virus replication. BHK
cells, in contrast, do not support viral replication. We
analysed whether the transgene cassette present in the
adenovirus vector can be mobilized such that it integrates
A
B
Figure 3. (A) Schematic representation of the plasmids pShuttle-H6 and pBK2272-HPRT. The neomycin resistance marker genes (neo) are indicated
as solid arrows. The Cre open reading frame is indicated as a shaded arrow. The PGK and the tk promoter are indicated as arrowheads. The HPRT
selection marker gene is indicated as a striped arrow. The primer binding sites (horizontal arrows) used for genotyping and the sizes of the expected
PCR products are indicated. (B) PCR analysis of DNA isolated from HEK 293 cells transfected with the indicated plasmids. The 2941-bp product is
generated from the non-recombined pBK2272-HPRT plasmid. The 421-bp PCR product is indicative of a recombinase mediated cassette exchange
between the PGKneo cassette (derived from plasmid pB2272-neo) and the PGK-HPRT cassette. Phage  DNA digested with HindIII and EcoRI was
used as molecular weight marker.
Figure 4. PCR analysis using the primer combination bcas3, bcas10
and neoint.4 on DNA isolated from representative cell clones derived
after electroporation of HM1 RMCE2272-98 cells with the plasmid
pShuttle-G5 and selection of the transfected cells in medium containing
200mg/ml of G418. The 1317-bp band is detected in all samples and
represents the unmodiﬁed b-casein allele. Cell clones modiﬁed by an
RMCE event, which has inserted the PGK-neo selection marker
cassette, display an additional 1023-bp PCR product. Phage  DNA
digested with HindIII and EcoRI was used as molecular weight marker.
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BHK cells were transiently transfected with the acceptor
plasmid pBK2272-HPRT and subsequently infected with
the adenovirus vector G5 or the control virus. As a
positive control the cells were also transfected with the
plasmid pMC1-Cre. In order to determine whether the
availability of the mobilizable transgene cassette is a
limiting factor, in a parallel reaction the infected cells
were also transfected with the plasmid pB2272-neo,
which corresponds exactly to the cassette present in the
viral vector. DNA was isolated from the transfected and
infected cells 24h post-infection and analysed by PCR
with the primer combination: CMVseq.1/PGK5/pBKpA.
In the absence of recombination a PCR product of 622bp
is generated by the primer pair pBKpA/PGK5, whereas
successful recombination is evidenced by the occurrence of
a 421-bp product derived from primer pair PGK5/
CMVseq.1 (Figure 5A).
As shown in Figure 5B transfection of HEK 293 cells
with the acceptor plasmid pBK2272-HPRT, the donor
plasmid pB2272-neo and the Cre expression plasmid
pMC1-Cre leads to the generation of a 421-bp product
indicative of a successful site-speciﬁc recombination. The
same product is also generated when the cells are infected
with the adenovirus G5 irrespective of whether the donor
plasmid pB2272-neo was co-transfected. This indicates
A
B
Figure 5. (A) Schematic representation of the linear plasmids pShuttle-G5, pBK2272-HPRT and the expected recombination product. The neomycin
resistance marker genes (neo) are indicated as solid arrows. The Cre open reading frame is indicated as a shaded arrow. The PGK and the tk
promoter are indicated as arrowheads. The copies of the b-globin insulator element (INS) are indicated as vertically striped boxes. The positions of
the lox2272 and loxP sites are marked by vertical arrows. (B) PCR analysis of DNA isolated from HEK 293 and BHK cells (as indicated)
transfected/infected with pBK2272-HPRT plus the indicated plasmids and virus vectors. The 622-bp PCR product is generated from the
non-recombined pBK2272-HPRT plasmid. The 421-bp PCR product (derived from the primer pair PGK5/CMVseq.1) is indicative of a recombinase
mediated cassette exchange between the PGK-neo cassette and the PGK-HPRT cassette. Phage  DNA digested with HindIII and EcoRI was used
as molecular weight marker.
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pressing suﬃcient amounts of Cre and to act as donor
of the 2272-neo cassette. The PCR analysis shown in
Figure 5B analyses the 30 end of the recombination event
(Figure 5A). Analysis of the 50 end of the recombination
event conﬁrms these results (data not shown). BHK cells
in contrast which do not allow replication of the adeno-
virus vector do only show the band indicative of an
RMCE event after co-transfection of the plasmids
pB2272-neo and pMC1-Cre. In addition, there is a faint
band detectable in the cells which have been transfected
with the plasmid pB2272-neo and infected with the
G5 virus.
In order to assess whether the abundance of Cre or the
neo-RMCE donor cassette is limiting for the RMCE
reaction two further experiments were carried out. First,
HEK 293 cells and BHK cells were transfected with the
plasmid pDSred-mito-2272neo. This plasmid carries a
PGKneo cassette ﬂanked by two tandem lox2272 sites
inserted between the CMV promoter and the open
reading frame of the red ﬂuorescent protein DSred-mito
gene. The neo-cassette prevents activation of the
DSred-mito gene. Cre removes the neo-cassette and the
ensuing gene expression can be detected as red ﬂuorescent
staining in the mitochondria of the cells. Infection of the
G5 virus was able to induce DSred-mito gene expression
both in HEK 293 and BHK cells even though expression
was much more abundant in HEK 293 where virus repli-
cation is possible (Figure 6A). This is conﬁrmed by PCR
using the primer pair DSred-1R/CMVseq.1 which yields a
529-bp product indicative of a site-speciﬁc recombination
event in both cell types. The product can be detected in
HEK 293 and BHK cells (albeit at a lower intensity)
indicating that there is suﬃcient Cre protein present in
the BHK cells to support recombination.
Subsequently, we used a lower concentration of the
G5 virus (MOIs of 0.1 and 0.3) in HEK 293 cells to
assess whether under these conditions additional transfec-
tion of a Cre-expression plasmid (pMC1-Cre) or the
RMCE plasmid pB2272-neo would augment RMCE. As
shown in Figure 6C the addition of extra mobilizable
transgene cassette DNA signiﬁcantly enhances RMCE fre-
quency (lane pB2272-neo+virus G5; Figure 6C). No sig-
niﬁcant diﬀerence is observed if the pMC1-Cre plasmid is
transfected in addition to infection with the virus G5
(Figure 6C). Real-time PCR analysis conﬁrms that there
is a 14-fold increase in RMCE product when the plasmid
pB2272-neo containing the transgene cassette is trans-
fected in addition to the G5 infection in HEK 293 cells
(Figure 6D). In contrast, transfection of the plasmid
pMC1-Cre in addition to the virus infection only
augments the occurrence of the RMCE product by
1.4-fold.
We then assessed whether the adenoviral vector would
also be able to support integration of the neo-selection
marker cassette from the virus into a target site
embedded into the genome. We therefore generated
a plasmid carrying a modiﬁed b-casein gene
B
A
D
λ
C
Figure 6. (A) Red ﬂuorescent staining in HEK 293 and BHK cells transfected with the plasmid pDSred-mito-2272-PGKneo and infected with the G5
adenovirus. Red staining of the mitochondria indicates the presence of the plasmid and the virus-derived Cre protein in the same cell. (B) PCR
analysis of DNA derived from the cells in A using the primer combination DSred1R/CMVseq.1. Recombination between the two identical lox2272
sites in the plasmid, which is a prerequisite for the activation of the red ﬂuorescent protein is indicated by the occurrence of a 529-bp band (marked
by the arrow). (C) PCR analysis of DNA isolated from HEK293 cells transfected with the indicated plasmids and infected with adenovirus G5 at an
MOI of 0.1. RMCE is detected using the primer pair pBKpA/neoint.4 which yields an indicative 1073bp product (marked by the arrow).
(D) Real-time PCR analysis of DNA isolated from HEK293 cells transfected with the indicated plasmids and infected with adenovirus G5 at an
MOI of 0.1 or 0.3 (as indicated). RMCE is detected using the primer pair PGK5/CMVseq.1 (as in Figure 5) which yields an indicative 421-bp
product. The amount of PCR product is shown as pg per 1000 cells.
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RMCE, and transfected it stably into HEK 293 cells
(Figure 7A). The stably transfected cells were subsequently
infected with the virus G5 or the control virus. Genomic
DNA was isolated 24h post-infection and analysed by
PCR. The primer combination bcas3/hytk1/neoint.4 was
used to detect recombination at the 30 end of the integrated
cassette. A 1147-bp PCR product (ampliﬁed by the primer
pair bcas3/hytk1) is detected in the unmodiﬁed b-casein
gene, whereas a 1028-bp product (ampliﬁed by the
primer pair bcas3/neoint.4) is indicative of a b-casein
gene modiﬁed by RMCE (Figure 7B). The primer combin-
ation bcas6/hytk2/PGK5 was used to assess recombin-
ation at the 50 end of the integrated cassette. A 936-bp
PCR product (ampliﬁed by the primer pair bcas6/hytk2)
is detected in the unmodiﬁed b-casein gene, whereas a
215-bp product (ampliﬁed by the primer pair bcas6/
PGK5) is indicative of a b-casein gene modiﬁed by
RMCE (Figure 7C). Recombination was readily detected
in HEK 293 cells transiently or stably transfected with the
pB-cas7-2272-hytk plasmid indicating that the G5 virus is
able to serve as both transgene donor and source of Cre
A
BC
Figure 7. (A) Schematic representation of the plasmid pB-bcas7-2272-hytk, the insert of the virus vector G5 and the resulting RMCE product. Exons
of the b-casein gene are indicated as shaded boxes, the neomycin and hytk selection marker genes are indicated as solid and shaded arrows,
respectively and the Cre ORF (Cre) is indicated as a vertically striped arrow. The PGK promoter elements directing expression of the selection
marker genes are indicated as black arrowheads. The positions of the lox2272 and loxP sites are marked by vertical arrows. The primer binding sites
(horizontal arrows) used for genotyping and the sizes of the expected PCR products are indicated. (B) PCR analysis of DNA isolated from HEK
293 cells transiently or stably transfected with pB-bcas7-2272-hytk. The cells were either co-transfected with the indicated plasmids or infected with
the indicated virus vectors 24h post-transfection. The 30 end of the RMCE reaction was analysed using the primer combination bcas3/neoint.4/hytk1.
Successful recombination at the loxP site is indicated by the presence of the 1023-bp PCR product. Non-recombined DNA yields a PCR product of
1147bp. Phage  DNA digested with HindIII and EcoRI was used as molecular weight marker. (C) The 50 end of the RMCE reaction was analysed
using the primer combination bcas6/PGK5/hytk2. Successful recombination at the lox2272 site is indicated by the presence of the 215-bp PCR
product. Non-recombined DNA yields a PCR product of 936bp. Phage  DNA digested with HindIII and EcoRI and the NEB PCR marker (New
England Biolabs) were used as molecular weight markers.
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cassette into a predeﬁned genomic site in HEK 293 cells.
Comparison of the relative intensities of the PCR products
representing the stably integrated b-casein gene and the
RMCE product demonstrates that infection with the G5
virus is signiﬁcantly more eﬃcient in mediating RMCE
than transfection of the plasmids pB2272-neo and
pMC1-Cre.
DISCUSSION
The goal for genome modiﬁcation in gene therapy and
transgenesis is that genome alterations can be introduced
rapidly and accurately. Cre recombinase has proved a
useful tool for genome modiﬁcations due to its high
activity in mammalian cells (29) and its high degree of
DNA sequence speciﬁcity. We show here that
Cre-mediated cassette exchange is highly dependent on
electroporation conditions and vector design. Our results
conﬁrm our expectations that a single contiguous segment
of DNA which carries both, the Cre expression cassette
and a mobilizable transgene cassette, is able to mediate
stable integration of the transgene into a genomic target.
However, the presence of an insulator element between the
two genes is essential for eﬃcient recombination to take
place. The requirement for the insulator element may
suggest that transcription of the gene cassettes can inter-
fere with Cre mediated recombination. Alternatively, tran-
scription of the neo cassette may reduce expression of the
neighboring Cre recombinase gene thus resulting in a di-
minished level of site-speciﬁc recombination. We and
others have demonstrated that adjacent transcription cas-
settes can silence each other (15,30).
An adenovirus vector which acts both as transgene
donor and source of Cre expression is able to mediate
site-speciﬁc transgene integration into extra-chromosomal
and chromosomal target sites. However, the vector is
only eﬃcient in cells which allow adenovirus vector
replication. This is largely due to the limiting amounts
of transgene cassette that can be generated in an infected
cell which does not support virus replication. This can
be concluded from the ﬁnding that augmenting the trans-
gene cassette by transfection signiﬁcantly increases the
RMCE frequency, whereas augmenting the Cre-
expression cassette does not. The limiting amounts of
transgene cassette may also be responsible for the diﬀerent
RMCE frequencies obtained with diﬀerent electropor-
ation conditions. The conditions which strongly favor
random integration over RMCE may not allow suﬃcient
quantities of transgene DNA to enter the cell, whereas the
conditions which strongly favor RMCE over random
integration do.
E1 gene deleted adenovirus vectors do not allow a sig-
niﬁcant degree of DNA replication in cells in which the
E1 gene product is not supplied exogenously. E1 encodes
the earliest viral gene product and is essential for the early
steps of virus DNA replication. This may limit the total
amount of viral DNA that is produced in an infected cell.
Therefore alternative adenovirus vector designs may be
used to enhance the concentration of viral DNA in the
infected cell.
Adenovirus vectors have been used successfully to
mediate integration of transgene cassettes using transpos-
able elements (e.g. sleeping beauty and L1) demonstrating
the usefulness of combining viral vectors with enzymes
mediating gene integration (albeit non-site-speciﬁc) to
improve transgene expression (31,32).
It has been shown that the speciﬁcity of site-speciﬁc re-
combinases can be modulated such that they recognize
sites existing in the human and animal genomes
(33,34). We show in here that an adenovirus vector con-
taining a Cre expression cassette and a transgene cas-
sette can mediate site-speciﬁc gene integration into a
genomic target site. In combination with Cre mutants
of altered site-speciﬁcity and viral vectors whose inability
to multiply in host cells is restricted at the step of
packaging rather than DNA replication this approach
may lead to vectors which allow site-directed insertion
of genes into mammalian genomes. This approach
can therefore be applied to the insertion of transgenes
encoding recombinant proteins in animals and may
also have implications for similar approaches in gene
therapy. This system can also be applied to any other re-
combinase system including the C31 recombinase
(33,35,36) and the  integrase (37), which mediate the
site-speciﬁc integration of transgenes into the host
genome.
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